chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nightmare, Nocturia, Pain, Paraesthesia, Pyrexia
Clinical narrative: Severe Asthma; pain at injection site; Rash at I she tin site the went down left arm, up shoulder and into neck; SOB; weakness; Coughing with taste of blood; running nose; watery eyes; fever; chills; muscle weakness to the point of falling down and dropping item; pain; numbness and tingling throughout body; numbness and tingling throughout body; flank pain; intermittent urinary inconstance; increased urination at night; nightmares; dizziness; blurred/double vision; ringing in ears; irregular body temperature; anxiety; depression; extreme fatigue; visual disturbance; I have been not been to work since second shot; This is a spontaneous report receive from a contactable consumer (Patient herself). A 41-year-old non-pregnant female patient (patient was not pregnant at the time of vaccination) received first dose BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection with false Lot number: EK5730) via intramuscularly on 18Dec2020 at 08:00 am to right arm (at the age of 41-years-old) and second dose with lot number: EK9231 via intramuscularly on 08Jan2021 at 08:00am to left arm both at single dose for COVID-19 immunization. Medical history included Migraines. Concomitant medications were not reported. On 08Jan2021 at 06:00pm, the patient experienced pain at injection site, rash at injection site went down left arm, up shoulder and into neck, SOB, fatigue, weakness, coughing with taste of blood, running nose, watery eyes, fever, chills Day after and progression: muscle weakness to the point of falling down and dropping item, pain, numbness and tingling throughout body, flank pain, intermittent urinary inconstance, increased urination at night, nightmares, dizziness, blurred/double vision, ringing in ears, irregular body temperature, cough tasting blood, anxiety, depression Today: SOB, couch tasting blood, extreme fatigue, visual disturbance, nightmares, anxiety, depression and she said , that she had not been able to work since her second shot. On 13Jan2021 patient underwent lab test included swab test results as negative. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Mar21 new onset of severe asthma was diagnosed. Outcome of events was not recovered.  Information about report seriousness has been requested; Sender's Comments: Considering the known safety profile of the drug and a plausible temporal association between the reported events and the suspect drug BNT162B2, a causal relationship cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rhinorrhoea, Tinnitus, Urinary incontinence, Vaccination site pain
Clinical narrative: Severe Asthma; pain at injection site; Rash at I she tin site the went down left arm, up shoulder and into neck; SOB; weakness; Coughing with taste of blood; running nose; watery eyes; fever; chills; muscle weakness to the point of falling down and dropping item; pain; numbness and tingling throughout body; numbness and tingling throughout body; flank pain; intermittent urinary inconstance; increased urination at night; nightmares; dizziness; blurred/double vision; ringing in ears; irregular body temperature; anxiety; depression; extreme fatigue; visual disturbance; I have been not been to work since second shot; This is a spontaneous report receive from a contactable consumer (Patient herself). A 41-year-old non-pregnant female patient (patient was not pregnant at the time of vaccination) received first dose BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection with false Lot number: EK5730) via intramuscularly on 18Dec2020 at 08:00 am to right arm (at the age of 41-years-old) and second dose with lot number: EK9231 via intramuscularly on 08Jan2021 at 08:00am to left arm both at single dose for COVID-19 immunization. Medical history included Migraines. Concomitant medications were not reported. On 08Jan2021 at 06:00pm, the patient experienced pain at injection site, rash at injection site went down left arm, up shoulder and into neck, SOB, fatigue, weakness, coughing with taste of blood, running nose, watery eyes, fever, chills Day after and progression: muscle weakness to the point of falling down and dropping item, pain, numbness and tingling throughout body, flank pain, intermittent urinary inconstance, increased urination at night, nightmares, dizziness, blurred/double vision, ringing in ears, irregular body temperature, cough tasting blood, anxiety, depression Today: SOB, couch tasting blood, extreme fatigue, visual disturbance, nightmares, anxiety, depression and she said , that she had not been able to work since her second shot. On 13Jan2021 patient underwent lab test included swab test results as negative. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Mar21 new onset of severe asthma was diagnosed. Outcome of events was not recovered.  Information about report seriousness has been requested; Sender's Comments: Considering the known safety profile of the drug and a plausible temporal association between the reported events and the suspect drug BNT162B2, a causal relationship cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Viral test, Vision blurred, Visual impairment
Clinical narrative: Severe Asthma; pain at injection site; Rash at I she tin site the went down left arm, up shoulder and into neck; SOB; weakness; Coughing with taste of blood; running nose; watery eyes; fever; chills; muscle weakness to the point of falling down and dropping item; pain; numbness and tingling throughout body; numbness and tingling throughout body; flank pain; intermittent urinary inconstance; increased urination at night; nightmares; dizziness; blurred/double vision; ringing in ears; irregular body temperature; anxiety; depression; extreme fatigue; visual disturbance; I have been not been to work since second shot; This is a spontaneous report receive from a contactable consumer (Patient herself). A 41-year-old non-pregnant female patient (patient was not pregnant at the time of vaccination) received first dose BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection with false Lot number: EK5730) via intramuscularly on 18Dec2020 at 08:00 am to right arm (at the age of 41-years-old) and second dose with lot number: EK9231 via intramuscularly on 08Jan2021 at 08:00am to left arm both at single dose for COVID-19 immunization. Medical history included Migraines. Concomitant medications were not reported. On 08Jan2021 at 06:00pm, the patient experienced pain at injection site, rash at injection site went down left arm, up shoulder and into neck, SOB, fatigue, weakness, coughing with taste of blood, running nose, watery eyes, fever, chills Day after and progression: muscle weakness to the point of falling down and dropping item, pain, numbness and tingling throughout body, flank pain, intermittent urinary inconstance, increased urination at night, nightmares, dizziness, blurred/double vision, ringing in ears, irregular body temperature, cough tasting blood, anxiety, depression Today: SOB, couch tasting blood, extreme fatigue, visual disturbance, nightmares, anxiety, depression and she said , that she had not been able to work since her second shot. On 13Jan2021 patient underwent lab test included swab test results as negative. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Mar21 new onset of severe asthma was diagnosed. Outcome of events was not recovered.  Information about report seriousness has been requested; Sender's Comments: Considering the known safety profile of the drug and a plausible temporal association between the reported events and the suspect drug BNT162B2, a causal relationship cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Chest X-ray, Electrocardiogram, Full blood count
Clinical narrative: Afib; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number unknown), via an unspecified route of administration in right arm on 09Mar2021 at 09.15 AM at single dose for COVID-19 immunization. Medical history included: allergy to penicillin and high blood pressure. Patient did not have COVID prior to vaccination and was not tested post vaccination. Approximately 8 hours after receiving the vaccine, on 09Mar2021 at 05.00 PM, the heart began racing very fast. Patient had to go to the Emergency Room. The doctor said it was atrial fibrillation. Patient received treatment with Cardizum 12.5 mg. Outcome of event was recovered.  Information regarding Lot/Batch number has been requested.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation
Clinical narrative: Afib; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number unknown), via an unspecified route of administration in right arm on 09Mar2021 at 09.15 AM at single dose for COVID-19 immunization. Medical history included: allergy to penicillin and high blood pressure. Patient did not have COVID prior to vaccination and was not tested post vaccination. Approximately 8 hours after receiving the vaccine, on 09Mar2021 at 05.00 PM, the heart began racing very fast. Patient had to go to the Emergency Room. The doctor said it was atrial fibrillation. Patient received treatment with Cardizum 12.5 mg. Outcome of event was recovered.  Information regarding Lot/Batch number has been requested.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test normal, Computerised tomogram head, Facial paralysis, Full blood count normal
Clinical narrative: experiencing facial paralysis in lips which progressed to the rest of right side of face; Bell's Palsy; Headache in right back portion of head; This is a spontaneous report from a contactable consumer (the patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: EN6202) via an unspecified route of administration, in the right arm on 02Mar2021 at 14:30 PM (at the age of 43 years).  Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medication taken within two weeks of vaccination included hydrochlorothiazid. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ibuprofen and experienced hypersensitivity. It was reported that the patient experienced headache in right back portion of head which started in PM on 05Mar2021. On 07Mar2021 the patient began experiencing facial paralysis in lips which progressed to the rest of right side of face. The patient went to the hospital emergency department. Bloodwork was normal. Computerized tomogram (CT) scan was noted as "unremarkable". He was diagnosed with Bell's Palsy and prescribed Valtrex and Prednisone. On 10Mar2021 he was still experiencing facial paralysis and headache. The clinical outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Metabolic function test
Clinical narrative: experiencing facial paralysis in lips which progressed to the rest of right side of face; Bell's Palsy; Headache in right back portion of head; This is a spontaneous report from a contactable consumer (the patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: EN6202) via an unspecified route of administration, in the right arm on 02Mar2021 at 14:30 PM (at the age of 43 years).  Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medication taken within two weeks of vaccination included hydrochlorothiazid. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ibuprofen and experienced hypersensitivity. It was reported that the patient experienced headache in right back portion of head which started in PM on 05Mar2021. On 07Mar2021 the patient began experiencing facial paralysis in lips which progressed to the rest of right side of face. The patient went to the hospital emergency department. Bloodwork was normal. Computerized tomogram (CT) scan was noted as "unremarkable". He was diagnosed with Bell's Palsy and prescribed Valtrex and Prednisone. On 10Mar2021 he was still experiencing facial paralysis and headache. The clinical outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Facial paralysis, Headache
Clinical narrative: experiencing facial paralysis in lips which progressed to the rest of right side of face; Bell's Palsy; Headache in right back portion of head; This is a spontaneous report from a contactable consumer (the patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: EN6202) via an unspecified route of administration, in the right arm on 02Mar2021 at 14:30 PM (at the age of 43 years).  Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medication taken within two weeks of vaccination included hydrochlorothiazid. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ibuprofen and experienced hypersensitivity. It was reported that the patient experienced headache in right back portion of head which started in PM on 05Mar2021. On 07Mar2021 the patient began experiencing facial paralysis in lips which progressed to the rest of right side of face. The patient went to the hospital emergency department. Bloodwork was normal. Computerized tomogram (CT) scan was noted as "unremarkable". He was diagnosed with Bell's Palsy and prescribed Valtrex and Prednisone. On 10Mar2021 he was still experiencing facial paralysis and headache. The clinical outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Fatigue, Headache, Hypoaesthesia oral, Inflammation
Clinical narrative: Date and time adverse event started: 3-5-21 @ 8:15PM, ITCHING TO HANDS. AT 10PM ITCHING STOPPED AND A BURNING SENSATION STARTED. 3-6-21 OPEN WAKENING, BODY IS ENTIRELY RED AND BURNING. 3-8-21 THROAT AND TONGUE STARTED TO NUMB INTO THE MOUTH. LUMP IN THROAT THAT RESULTED IN AN ER VISIT. PREDNISONE, BENADRYL, PEPCID IV WAS GIVEN. MEDS HELPED WIKTH MOUTH AND THROAT ISSUES. WAWS GIVEN A 3 DAY SUPPLY OF PREDNISONE, PEPCID, AND TO BENADRYL & TOLD TO SEE HER PCP. 3-9-21 CALLED PCP,  WHO REFERRED HER TO HER ALLERGIST. ALLERGIST SAW HER THAT SAME DAY 3-9-21 REPORTED TO CONTINUE MEDS MINUS BENADRYL AND TO TAKE ZYRETC BID.  CALLER REPORTS IF SHES LATE ON THE ZYRETC HER SENSATION IS FROM STINGING TO BURNING. ALLERGIST SENT HER BACK TO THE ED WHERE THEY RAN BLOOD WORK. WAS TOLD EVERYTHING WAS NORMAL WITH THE EXCEPTION OF "ELEVATION OF INFLAMMATION" MARKERS. WAS DSICHARGED AND TOLD TO F/U WITH PCP. SPOKE WITH ALLERGIST WHO THEN REFERRED HER TO healthcare facility. PCP TOLD HER TO HOLD OFF ON healthcare facility AND MADE CHANGES TO MEDS; PREDNISONE TAPERED DOSE FOR 18 DAYS, ZYRTEC & PEPCID BID FOR 4 WEEKS. APRIL 8TH FOLLOWING UP WITH PCP AFTER MEDS.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pain of skin, Pruritus
Clinical narrative: Date and time adverse event started: 3-5-21 @ 8:15PM, ITCHING TO HANDS. AT 10PM ITCHING STOPPED AND A BURNING SENSATION STARTED. 3-6-21 OPEN WAKENING, BODY IS ENTIRELY RED AND BURNING. 3-8-21 THROAT AND TONGUE STARTED TO NUMB INTO THE MOUTH. LUMP IN THROAT THAT RESULTED IN AN ER VISIT. PREDNISONE, BENADRYL, PEPCID IV WAS GIVEN. MEDS HELPED WIKTH MOUTH AND THROAT ISSUES. WAWS GIVEN A 3 DAY SUPPLY OF PREDNISONE, PEPCID, AND TO BENADRYL & TOLD TO SEE HER PCP. 3-9-21 CALLED PCP,  WHO REFERRED HER TO HER ALLERGIST. ALLERGIST SAW HER THAT SAME DAY 3-9-21 REPORTED TO CONTINUE MEDS MINUS BENADRYL AND TO TAKE ZYRETC BID.  CALLER REPORTS IF SHES LATE ON THE ZYRETC HER SENSATION IS FROM STINGING TO BURNING. ALLERGIST SENT HER BACK TO THE ED WHERE THEY RAN BLOOD WORK. WAS TOLD EVERYTHING WAS NORMAL WITH THE EXCEPTION OF "ELEVATION OF INFLAMMATION" MARKERS. WAS DSICHARGED AND TOLD TO F/U WITH PCP. SPOKE WITH ALLERGIST WHO THEN REFERRED HER TO healthcare facility. PCP TOLD HER TO HOLD OFF ON healthcare facility AND MADE CHANGES TO MEDS; PREDNISONE TAPERED DOSE FOR 18 DAYS, ZYRTEC & PEPCID BID FOR 4 WEEKS. APRIL 8TH FOLLOWING UP WITH PCP AFTER MEDS.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin tightness
Clinical narrative: Date and time adverse event started: 3-5-21 @ 8:15PM, ITCHING TO HANDS. AT 10PM ITCHING STOPPED AND A BURNING SENSATION STARTED. 3-6-21 OPEN WAKENING, BODY IS ENTIRELY RED AND BURNING. 3-8-21 THROAT AND TONGUE STARTED TO NUMB INTO THE MOUTH. LUMP IN THROAT THAT RESULTED IN AN ER VISIT. PREDNISONE, BENADRYL, PEPCID IV WAS GIVEN. MEDS HELPED WIKTH MOUTH AND THROAT ISSUES. WAWS GIVEN A 3 DAY SUPPLY OF PREDNISONE, PEPCID, AND TO BENADRYL & TOLD TO SEE HER PCP. 3-9-21 CALLED PCP,  WHO REFERRED HER TO HER ALLERGIST. ALLERGIST SAW HER THAT SAME DAY 3-9-21 REPORTED TO CONTINUE MEDS MINUS BENADRYL AND TO TAKE ZYRETC BID.  CALLER REPORTS IF SHES LATE ON THE ZYRETC HER SENSATION IS FROM STINGING TO BURNING. ALLERGIST SENT HER BACK TO THE ED WHERE THEY RAN BLOOD WORK. WAS TOLD EVERYTHING WAS NORMAL WITH THE EXCEPTION OF "ELEVATION OF INFLAMMATION" MARKERS. WAS DSICHARGED AND TOLD TO F/U WITH PCP. SPOKE WITH ALLERGIST WHO THEN REFERRED HER TO healthcare facility. PCP TOLD HER TO HOLD OFF ON healthcare facility AND MADE CHANGES TO MEDS; PREDNISONE TAPERED DOSE FOR 18 DAYS, ZYRTEC & PEPCID BID FOR 4 WEEKS. APRIL 8TH FOLLOWING UP WITH PCP AFTER MEDS.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Burning sensation, Erythema, Hypoaesthesia oral, Pain
Clinical narrative: Date and time adverse event started: 3-5-21 @ 8:15PM, ITCHING TO HANDS. AT 10PM ITCHING STOPPED AND A BURNING SENSATION STARTED. 3-6-21 OPEN WAKENING, BODY IS ENTIRELY RED AND BURNING. 3-8-21 THROAT AND TONGUE STARTED TO NUMB INTO THE MOUTH. LUMP IN THROAT THAT RESULTED IN AN ER VISIT. PREDNISONE, BENADRYL, PEPCID IV WAS GIVEN. MEDS HELPED WIKTH MOUTH AND THROAT ISSUES. WAWS GIVEN A 3 DAY SUPPLY OF PREDNISONE, PEPCID, AND TO BENADRYL & TOLD TO SEE HER PCP. 3-9-21 CALLED PCP,  WHO REFERRED HER TO HER ALLERGIST. ALLERGIST SAW HER THAT SAME DAY 3-9-21 REPORTED TO CONTINUE MEDS MINUS BENADRYL AND TO TAKE ZYRETC BID.  CALLER REPORTS IF SHES LATE ON THE ZYRETC HER SENSATION IS FROM STINGING TO BURNING. ALLERGIST SENT HER BACK TO THE ED WHERE THEY RAN BLOOD WORK. WAS TOLD EVERYTHING WAS NORMAL WITH THE EXCEPTION OF "ELEVATION OF INFLAMMATION" MARKERS. WAS DSICHARGED AND TOLD TO F/U WITH PCP. SPOKE WITH ALLERGIST WHO THEN REFERRED HER TO healthcare facility. PCP TOLD HER TO HOLD OFF ON healthcare facility AND MADE CHANGES TO MEDS; PREDNISONE TAPERED DOSE FOR 18 DAYS, ZYRTEC & PEPCID BID FOR 4 WEEKS. APRIL 8TH FOLLOWING UP WITH PCP AFTER MEDS.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal hypoaesthesia, Pruritus, Sensation of foreign body
Clinical narrative: Date and time adverse event started: 3-5-21 @ 8:15PM, ITCHING TO HANDS. AT 10PM ITCHING STOPPED AND A BURNING SENSATION STARTED. 3-6-21 OPEN WAKENING, BODY IS ENTIRELY RED AND BURNING. 3-8-21 THROAT AND TONGUE STARTED TO NUMB INTO THE MOUTH. LUMP IN THROAT THAT RESULTED IN AN ER VISIT. PREDNISONE, BENADRYL, PEPCID IV WAS GIVEN. MEDS HELPED WIKTH MOUTH AND THROAT ISSUES. WAWS GIVEN A 3 DAY SUPPLY OF PREDNISONE, PEPCID, AND TO BENADRYL & TOLD TO SEE HER PCP. 3-9-21 CALLED PCP,  WHO REFERRED HER TO HER ALLERGIST. ALLERGIST SAW HER THAT SAME DAY 3-9-21 REPORTED TO CONTINUE MEDS MINUS BENADRYL AND TO TAKE ZYRETC BID.  CALLER REPORTS IF SHES LATE ON THE ZYRETC HER SENSATION IS FROM STINGING TO BURNING. ALLERGIST SENT HER BACK TO THE ED WHERE THEY RAN BLOOD WORK. WAS TOLD EVERYTHING WAS NORMAL WITH THE EXCEPTION OF "ELEVATION OF INFLAMMATION" MARKERS. WAS DSICHARGED AND TOLD TO F/U WITH PCP. SPOKE WITH ALLERGIST WHO THEN REFERRED HER TO healthcare facility. PCP TOLD HER TO HOLD OFF ON healthcare facility AND MADE CHANGES TO MEDS; PREDNISONE TAPERED DOSE FOR 18 DAYS, ZYRTEC & PEPCID BID FOR 4 WEEKS. APRIL 8TH FOLLOWING UP WITH PCP AFTER MEDS.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Blood test, Computerised tomogram, Diarrhoea, Electrocardiogram
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Hypothermia, Lumbar puncture, Magnetic resonance imaging, Shock
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Urine analysis, Vomiting
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Blood potassium, Blood pressure measurement, Body temperature, Body temperature abnormal
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Electrocardiogram, Electrocardiogram QT prolonged
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Hypokalaemia, Hypotension, Illness, Lactic acidosis
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Metabolic encephalopathy, Palpitations, Shock, Troponin
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin increased, Vomiting
Clinical narrative: Hypotension/blood pressure was dangerously low; Racing heart; shortness of breath; threw up; Very dizzy; very sick; Diarrhea; I was no longer responsive; Abnormal ECG; Elevated troponin; Shock; Acidosis, lactic; Acute hypokalemia/potassium was also very low; Acute metabolic encephalopathy; my temperature was 90 degrees; I do not remember anything after that; prolonged QT; This is a spontaneous report from a contactable consumer (the patient). A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on 19Feb2021 12:00 at age of 26-year-old at single dose for COVID-19 immunisation. No other vaccine in four weeks. Medical history included gastrooesophageal reflux disease (GERD), anemia, and eosinophilic esophagitis. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications in two weeks included drospirenone, ethinylestradiol (SYEDA), desvenlafaxine succinate, and omeprazole, all taken for an unspecified indication from an unspecified date. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) via an unspecified route of administration in left arm on 28Jan2021 at age of 26-year-old at 03:45 PM for COVID-19 immunization. The patient woke up at 3:00 am on Sunday the 21Feb2021 with a racing heart and shortness of breath. She got out of bed and threw up in the toilet. She laid down on the bathroom floor because she felt very dizzy and very sick. Thankfully, her boyfriend woke up and tried to help her. She had diarrhea and she did not remember anything after that. Her boyfriend said he helped her off the toilet safely and put her on the floor, but she was no longer responsive. He called 911 and she was taken to the ER. She did not wake up until around 10 the next day in the ICU. While she was very sick, her blood pressure was dangerously low, her temperature was 90 degrees, and her potassium was also very low. She had an abnormal ECG with a prolonged QT. She was in the hospital until Thursday. They did not find anything wrong with her heart or brain, or anything else. Discharge diagnosis included: (1) Elevated troponin, (2) Shock, (3) Acidosis, lactic, (4) Endotracheally intubated, (5) Acute hypokalemia, (6) Acute metabolic encephalopathy, (7) Hypotension. The events onset date was 21Feb2021 at 3:00 AM. The events resulted in: Emergency room/department or urgent care, Hospitalization in 2021, Life threatening illness (immediate risk of death from the event)]. The patient received potassium and IV fluids to treat the events. The outcome of the events was recovered in 2021.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Injection site pain, Paraesthesia
Clinical narrative: Within 45 minutes of receiving the first Moderna vaccination on 3/6/21, Patient developed numbness and tingling to the left side of his face which continued for the subsequent five days which led him to present to the ER on 3/11/21. Patient seen with exam findings suggestive of recurrence of trigeminal neuritis which he experienced in the past. Patient denied fevers, chills, cough, SOB, chest pain, headache, changes in vision, neck pain, dizziness, changes in hearing, N/V, numbness or tingling in his arms or legs. Patient did have subtle diminished sensation of Trigeminal nerve (V1,V3), no decreased muscle tone or strength. Patient had no known tick bite. He was then  discharged with empiric antiviral and prednisone.  He then presented back to Hospital ER on 03/14/2021 with ongoing symptoms of left-sided facial paresthesias and new onset tingling and numbness to the entire left side of his face, left arm and left leg which began on 3/12/21.  He also reported some abnormality in his position sense.  He was endorsing subjective weakness on the left side of his body.  He denied fevers, chills, headache, cough, shortness of breath, or history of tick bite.  Vital signs were significant for blood pressure 136/83 with a heart rate of 84. His neurological examination was normal.  Complete metabolic panel was performed along with a CBC with differential.  Lyme screen negative.  Brain MRI normal findings.  He was without evidence of Bell's Palsy.  Case was reviewed with neurologist, who agreed with the workup.  Reassurance was provided and referral was placed to outpatient Neurology. The patient was established with Dr. and  had a visit on 3/17/21. Per patient, Dr. was  concerned about Guillain-Barre. He was then admitted to the hospital on 3/17/21 for further work-up including a lumbar puncture. LP 3/19/21 WNL, EMG negative. He was discharged on 3/19/21 with diagnosis of likely allergic reaction to vaccination. Symptoms of numbness/tingling and weakness to left arm has almost entirely resolved by 3/24. He continues with very mild residual paresthesias to left side of face, symptoms improving as of today 3/25